U.S. markets close in 5 hours 4 minutes
  • S&P 500

    -100.29 (-2.96%)
  • Dow 30

    -821.13 (-2.99%)
  • Nasdaq

    -351.96 (-3.08%)
  • Russell 2000

    -39.23 (-2.47%)
  • Crude Oil

    -2.05 (-5.18%)
  • Gold

    -35.90 (-1.88%)
  • Silver

    -1.36 (-5.56%)

    -0.0058 (-0.49%)
  • 10-Yr Bond

    -0.0170 (-2.19%)

    -0.0070 (-0.53%)

    -0.1990 (-0.19%)

    -647.74 (-4.72%)
  • CMC Crypto 200

    -13.82 (-5.07%)
  • FTSE 100

    -183.05 (-3.20%)
  • Nikkei 225

    -67.29 (-0.29%)

United Cannabis Corporation Opens Colorado Hemp Testing Facility

Company Continues To Expand Its Industrial Hemp Service Offerings

DENVER, CO / ACCESSWIRE / January 15, 2019 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that it has launched an industrial hemp testing facility in Golden, Colorado.

The Company will provide independent testing for processors and manufacturers working under the 2018 Federal Farm Bill and Colorado's Department of Agriculture's Industrial Hemp Program. The facility is currently offering potency testing services, with terpene profiling, residual solvent analysis and heavy metal testing to follow.

Chad Ruby, Chief Operating Officer of United Cannabis, commented on the announcement, "We have been performing our own internal testing for the last several months and are now ready to offer our services to the entire hemp industry. Testing is an increasingly important component of any hemp-related business, for processors, manufacturers, formulators and resellers looking to ensure their end products are produced as intended."

"Our testing specialists and established protocols enable customers to authenticate their inventory so that they can market their products with confidence in both formulation and regulatory compliance."

About United Cannabis Corporation

United Cannabis Corporation is a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company has long advocated the application of cannabinoids for medical applications and is building a platform for designing targeted therapies to increase the quality of life for patients around the world. Most of the Company's products are patent protected, first in class medicines with applications to a global market. United Cannabis trades on the OTCQB under the symbol CNAB.

For further information, please visit www.unitedcannabis.us.


Phone: 303-386-7321

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

SOURCE: United Cannabis Corporation